tenaya therapeutics Tenaya Therapeutics, специализирующаяся на сердечно-сосудистых заболеваниях, на IPO предложила большее количество акций 1

Tenaya Therapeutics, specialized in cardiovascular diseases, offered more shares at the IPO

Biotechnology company Tenaya Therapeutics, developing several drugs for the treatment of cardiovascular diseases in the preclinical stage of research, attracted 180 million dollars, releasing 12 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.